India Globalization Capital (IGC) is a clinical-stage pharmaceutical company based in Bethesda, MD. They are focused on developing innovative drugs to address the unmet medical needs of patients with neurological disorders, particularly Alzheimer's disease. With a novel approach and promising results, IGC's drugs have the potential to change lives and make a significant impact on the millions of individuals affected by this debilitating condition.
Through their research and development efforts, IGC aims to provide effective treatments for Alzheimer's disease, including addressing agitation, a common symptom in patients. With a commitment to scientific excellence and a dedication to improving the health and well-being of patients and their families, IGC is at the forefront of advancing the understanding and treatment of neurological disorders.
Generated from the website